Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
Frontiers | Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
Biomedicines | Free Full-Text | Current Trends in Cancer Immunotherapy
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
Immunological characterization of hepatocellular carcinoma
T follicular helper cells in cancer: Trends in Cancer
Beneficial autoimmunity improves cancer prognosis | Nature Reviews Clinical Oncology
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Frontiers | Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy
IJMS | Free Full-Text | The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity | Cell Research
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing: Molecular Therapy - Methods & Clinical Development
Cancers | Free Full-Text | Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
Cells | Free Full-Text | The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
